Biotechnology industry in Italy

Last updated

Biotechnology industry in Italy is a highly innovative and fast-growing sector dedicated to research. At the end of 2019, there are 696 biotech companies active in Italy. [1]

Contents

Industry

The turnover exceeds 12 billion euros, the number of employees exceeds 13,000 units. Between 2017 and 2019, over 50 new innovative start-ups active in biotechnology were registered. [2]

Healthcare

Vaccine

In the laboratories of the IRBM Science Park a team of Italian and American researchers has developed the Chad3Ebola-Zaire anti-ebola vaccine, a monovalent adenovirus capable of neutralizing the «Zaire» strain of the virus, conceived and produced by OKAIROS, a biotech company founded by Prof. Riccardo Cortese, with whom IRBM set up the Advent equal joint venture.

Agricultural biotechnology

Research

The research intensity of the biotech sector is significantly higher than that found for the Italian industry as a whole. [9]

Organizations

Ministries

Agencies

Science parks and incubators

See also

Related Research Articles

<span class="mw-page-title-main">Liga Veneta Repubblica</span> Political party in Veneto

Liga Veneta Repubblica is a Venetist political party in Veneto, Italy. The party maintains a mildly separatist position and campaigns for the self-government of Veneto.

<span class="mw-page-title-main">Italia Nostra</span> Italian conservation organization

Italia Nostra is an Italian not for profit organization dedicated to the protection and promotion of the country’s historical, artistic and environmental patrimony.

<span class="mw-page-title-main">Lega Liguria</span> Political party in Liguria

Lega Liguria, whose complete name is Lega Liguria per Salvini Premier, is a regionalist political party active in Liguria. Established in 1987, it was one of the founding "national" sections of Lega Nord (LN) in 1991 and has been the regional section of Lega per Salvini Premier (LSP) in Liguria since 2020.

Attilio Celant, 2nd Class / Grand Officer of the Order of Merit of the Italian Republic, is an Italian economist, geographer and academic.

<span class="mw-page-title-main">Luca Garritano</span> Italian footballer (born 1994)

Luca Garritano is an Italian professional footballer who plays as a midfielder or left winger for Serie A club Frosinone.

<span class="mw-page-title-main">Democratic Centre (Italy)</span> Political party in Italy

Democratic Centre is a centrist, Christian leftist and social-liberal political party in Italy. Most of its members, including its leader Bruno Tabacci, are former Christian Democrats.

<span class="mw-page-title-main">Banca Carige</span> Italian bank based in Genoa, Italy

Banca Carige S.p.A., historically known as Cassa di Risparmio di Genova e Imperia (Ca.Ri.Ge.) was an Italian bank based in Genoa, with more than 500 bank branches in Italy, prior to its acquisition by BPER Banca in February 2022. The predecessor of the bank, a mount of piety, was founded in 1483 in Genoa, the Republic of Genoa. Banca Carige and its subsidiaries were known as Banca Carige Group. The banking group was one of the large banking groups in Italy, and as such, was supervised by the European Central Bank. In 2017, the banking group had 529 branches throughout Italy, with one branch in Nice, France, about 37.2% of branches were located in the home region Liguria. In November 2022, Banca Carige was fully incorporated into BPER Banca and ceased to exist as a separate entity.

<span class="mw-page-title-main">Accademia di Belle Arti di Perugia</span> Fine arts school in Perugia, Italy

The Accademia di Belle Arti di Perugia is a private tertiary academy of art in Perugia, in Umbria in central Italy. It is not one of the 20 official Italian state academies of fine art, but is legally recognised by the Ministero dell'Istruzione, dell'Università e della Ricerca, the Italian ministry of education and research, which gives its full name as Accademia di Belle Arti Legalmente Riconosciuta di Perugia "Pietro Vannucci". The academy became an autonomous degree-awarding institution under law no. 508 dated 21 December 1999.

rVSV-ZEBOV vaccine Vaccine against Ebola virus disease

Recombinant vesicular stomatitis virus–Zaire Ebola virus (rVSV-ZEBOV), also known as Ebola Zaire vaccine live and sold under the brand name Ervebo, is an Ebola vaccine for adults that prevents Ebola caused by the Zaire ebolavirus. When used in ring vaccination, rVSV-ZEBOV has shown a high level of protection. Around half the people given the vaccine have mild to moderate adverse effects that include headache, fatigue, and muscle pain.

Marche 2020 – Party of Marche is a regional centrist and Christian-democratic political party in Marche, Italy.

The Lazzaro Spallanzani National Institute for Infectious Diseases is an infectious disease hospital in the Italian city of Rome. The institute is named for the eighteenth-century Italian biologist Lazzaro Spallanzani.

<span class="mw-page-title-main">Gelmini reform</span> Italian educational reform

The Gelmini reform refers to the set of acts of the Italian Republic – issued during the Berlusconi IV Cabinet – concerning the education sector in Italy.

<span class="mw-page-title-main">2020 Italian by-elections</span> Special elections in Italy to fill vacancies

The 2020 Italian by-elections were called to fill seats in the Parliament that became vacant after the 2018 general elections. In 2020, by-elections were held for the Chamber of Deputies the Senate of the Republic.

<span class="mw-page-title-main">COVID-19 pandemic in Italy</span> Ongoing viral pandemic in Italy

The COVID-19 pandemic in Italy is part of the ongoing pandemic of coronavirus disease 2019 caused by severe acute respiratory syndrome coronavirus 2.

<span class="mw-page-title-main">COVID-19 vaccination in Italy</span> Immunization plan against COVID-19 in Italy

The COVID-19 vaccination campaign in Italy is a mass immunization campaign that was put in place by the Italian government in order to respond to the ongoing COVID-19 pandemic. It started on 27 December 2020, together with most countries in the European Union.

Between 2020 and 2022 hundreds of people from all over Italy protested against COVID-19 regulations. The protests ended with the abolishment of the majority of restrictions in June 2022. After the 2022 Italian general election in September, the remaining restrictions were removed completely by the Meloni Cabinet after Giorgia Meloni began serving as Prime Minister in October 2022.

<span class="mw-page-title-main">Timeline of the COVID-19 pandemic in Italy</span>

The following is a timeline of the COVID-19 pandemic in Italy.

<span class="mw-page-title-main">NOI Techpark</span>

NOI Techpark is the science and technology park of South Tyrol that hosts 4 research institutes, 4 Faculties of the Free University of Bozen-Bolzano, 40 scientific laboratories, 40 companies and 30 start-ups. Inaugurated in Bolzano in October 2017, it is the result of an urban redevelopment project. The structure is managed by NOI Spa, In-House company of the Autonomous Province of Bolzano.

<span class="mw-page-title-main">Riccardo Cortese</span> Italian scientist and entrepreneur

Riccardo Cortese was an Italian scientist, entrepreneur, and innovator in the field of gene expression, drug discovery and genetic vaccines. His work led to the development of novel therapeutic strategies for the prevention and cure of viral infections, including HIV, HCV, Ebola and RSV. He pioneered a novel platform technology based on simian adenoviral vectors for prophylactic and therapeutic vaccines, and authored more than 300 publications in peer-reviewed journals in the field of gene expression, transcriptional control, molecular virology and immunology.

Genertel is an Italian insurance company based in Trieste, Italy. It's the first online insurance company in Italy.
Part of the Generali Group since its foundation, from 2013 Genertel has been headed by Generali Italia.

References

  1. "La fotografia delle imprese di biotecnologie in Italia". assobiotec.federchimica.it. assobiotec.federchimica.it. Retrieved 3 August 2020.
  2. "La fotografia delle imprese di biotecnologie in Italia". assobiotec.federchimica.it. assobiotec.federchimica.it. Retrieved 3 August 2020.
  3. "Ebola, con il vaccino sviluppato in italia si ottiene l'immunità per 10 mesi". La Repubblica. 7 September 2014. Retrieved 26 November 2015.
  4. "Vaccino Oxford-Pomezia, a settembre 400 milioni di dosi: accordo con multinazionale Astrazeneca. Fondi anche dagli Usa". ilmessaggero.it. ilmessaggero.it. Retrieved 3 August 2020.
  5. "The Jenner Institute signs an agreement with Advent to develop a novel coronavirus vaccine". IRBM. Archived from the original on 19 January 2021. Retrieved 3 August 2020.
  6. "Vaccino Covid-19, sprint di azienda italiana: a fine aprile i test sull'uomo". ilsole24ore.com. ilsole24ore.com. 13 April 2020. Retrieved 3 August 2020.
  7. "Vaccino italiano, via ai test sull'uomo allo Spallanzani". ilsecoloxix.it. ilsecoloxix.it. 7 August 2020. Retrieved 8 August 2020.
  8. "Vaccino italiano, 3.000 candidati (anche medici): primi test su 3 volontari a fine agosto allo Spallanzani". ilmessaggero.it. ilmessaggero.it. 10 August 2020. Retrieved 12 August 2020.
  9. "La fotografia delle imprese di biotecnologie in Italia". assobiotec.federchimica.it. assobiotec.federchimica.it. Retrieved 3 August 2020.